thought expect
dive retail earn
natur grocer vitamin cottag
full comment requir non-u analyst conflict disclosur
pleas click link
compel option transform shift specialti initi op
expand team drive deal volum higher gener increment accret
buy apptio share
recap model updat
takeaway non-deal roadshow cfo
reposit market
review model updat
on-going tenant issu persist significantli weigh result outlook
see dose respons efficaci fall st expect
dawn roman empir analyst meet preview
revisit model post dsuvia approv recent financ chang view
outlin catalyst differ posit
download model updat rams confirm safeti seen palisad
stay cours maintain target outperform
steadi goe reiter outperform
sound silenc athena report soft result
takeaway ceo meet
result take busi
price prior day market close estimate unless otherwis note
updat aasld day summari
gener pharma data
point tell us
updat loan week
hd/low tweak pt stock
addit support go-forward
 of daili
news nashvil
athn compani present
preview cheat sheet
earli sign potenti inflect point
consumer/rx separ analysi re-set ep still lack upsid level
control control
misunderstand strong quarter result
fxr nash look modest earli hbv econom burden nash
told us thesi cyclic upturn come
week novemb
largest increas largest declin
never dull moment start weekli follow earn data heavi week
weekli perspect healthcar industri compani news valuat updat
continu digest learn last week
top investor question week payment processor servic
 spak micro-mobl
specialti pharma
focus week
takeaway
bancanalyst associ boston
oil strategi spotlight chines
technolog internet media
letter abu dhabi opec cours
sever notabl big move period closer look
year theme focus relev age big data
news nashvil
novemb new york citi
find research
insight www rbcinsightresearch com global research destin web contact capit market sale
repres access global research site use ipad app research
valu usd unless otherwis note
valu usd unless otherwis note
compel option transform shift specialti initi op
uniqu stori dcf valu current larg high barrier gener
base busi roughli cover equiti valu leav compel option two
sizabl brand opportun phase data expect provid
avenu unlock signific amount seemingli untap valu near-
term price target impli potenti near doubl share back
manag team track record
initi coverag outperform rate target
high barrier base busi larg develop compani
osmodex proprietari technolog hold strateg valu cash flow
perspect larg cover equiti valu
first key pipelin product blepharoptosi droopi eyelid
forecast peak un-risk adjust revenu million
follow shortli thereaft ontinua er muscl spastic multipl
sclerosi ms util osmodex technolog forecast peak un-risk adjust
revenu million
oper issu remain bottom believ ebitda could
leverag high dividend suspend difficult convers
custom could curtail futur growth quick fix turnaround long
pt revis forecast
new ceo doug delgrosso work cut ss seat
oper issu launch ineffici persist add financi
flexibl assist de-lever dividend suspend credit agreement
coven increas difficult convers
custom fix current unprofit unsustain busi ask
new busi
preliminari thought ebitda y/i guidanc given
forecast ebitda y/i high level thought
seat issu aros suspect earn level could
similar improv ss issu persist though
y/i basi could improv yfai interior issu took big step
expect continu commodities/fx/freight/labor less favor softer
global product especi key region china sg alon favor
rein spend temporari basi
coven amend support view ebitda significantli
valu usd unless otherwis note
valu usd unless otherwis note
expand team drive deal volum higher gener increment
encourag ad three new senior level execut
team believ hire enabl compani aggress pursu
new acquisit develop opportun invest drive
strong extern growth creat increment valu sharehold therefor
reiter outperform rate rais price target
ad three senior level execut part sourc new invest
opportun integr newli acquir develop facil
compani build develop pipelin recent reach
agreement woolworth develop three autom facil
australia announc earn call sign loi anoth
manag previous note identifi custom market
driven develop project total aggreg invest billion
deal could start next year
therefor believ near-term develop pace exceed
compani long-term annual target million addit
compani also focus acquisit note healthi
pipelin opportun
same-stor portfolio gener strong cash noi growth
tune constant currenc ytd gener averag
growth
buy apptio share
maintain maelstrom softwar offer buy
share given risk modest deceler growth think
valuat premium current share price modest premium
pt fair
apptio enter definit agreement acquir vista equiti
partner share repres premium friday close
premium pt think valuat fair given risk
moder subscript revenu growth
merger agreement includ go shop provis think risk
higher bid rel low given premium apptio size rel
limit set potenti strateg suitor rais pt expect
deal close
share pay apptio equat annual
recur revenu ev/ ev/ estim
note public life apptio trade ntm ev/
valu usd unless otherwis note
valu usd unless otherwis note
recap model updat
updat model financi result essenti
line includ zenium acquisit impact guidanc midpoint remain
revenu ebitda ffo/sh reiter
outperform share base discount valuat vs peer
favor growth prospect europ two largest market london frankfurt
updat model financi result essenti
line includ zenium acquisit impact guidanc midpoint remain
revenu ebitda ffo/sh
revenues/ebitda compar
primarili no-margin higher meter power pass-through reimburs
ffo/sh affo/sh interconnect revenu increas
y/i new interconnect book total zenium
acquisit close end august contribut revenu
ebitda margin price target declin slightli
takeaway non-deal roadshow cfo
recent host non-deal roadshow wolk cfo meet
increas convict level estim
consensu revenu outlook call mid-single-digit organ
growth exclud zytiga sale delay gener zytiga plu rel
model increas price target reiter outperform
pharmaceut segment solid foot head jnj major brand
oncolog immunolog darzalex imbruvica stelara
tremfya stellar expect strength continu
new indic four late stage trial soon file
medic devic better orthoped busi
recov segment stage gradual recoveri organ growth
reach electrophysiolog vision advanc surgeri done
zytiga gener eros competit materi impact
guidanc jnj guidanc impli revenu ep
revenu guidanc repres organ growth
believ share carri posit momentum next year
share gener total return outpac large-cap med-tech
coverag drg index compar believ
share perform driven primarili strength wit
valu usd unless otherwis note
valu usd unless otherwis note
reposit market
snmp cut distribut re-affirmed ebitda guidanc snmp
yield prior cut yet trade sharpli announc
indic messag ahead cut ideal howev market
give snmp credit pay-out coverag think reaction
friday overdon even question remain sn perform go-
result snmp report ebitda million line
street consensu million estim million
dcf prefer provid total coverag common
distribut
distribut cut snmp cut distribut
annual snmp also re-affirmed guidanc although think snmp
come low end would given snmp line sight
coverag leverag prior pay-out howev market
give credit metric view cut make sens
significantli improv snmp financi flexibl distribut coverag
snmp may look growth project particularli in-basin frac
may allevi downstream bottleneck
semg result miss expect semg lower midpoint
guidanc partial one-tim issu unanticip tank start-up cost
inventori time issu affect see linger near-term
challeng cush re-contract leverag remain posit semg
canadian growth opportun increas exposur downstream face
activ lower estim price target maintain
accret new growth project drive increment growth
beyond pipeston pipelin support activ montney
underpin take pay contract gener return
ebitda moor pipelin enhanc connect
hfotco gener return ebitda conserv forecast
evalu potenti new project leverag exist asset base although
semg provid limit detail manag note project involv
mix exist new asset could gener attract return semg
preserv qualiti crude oil provid competit tariff
shipper watch potenti open season
report adjust ebitda our/consensu
estim inventori time suppli logist
unexpect start-up cost associ new tank hfotco drove
miss semg expect adjust ebitda rang
midpoint
midpoint note semg ebitda guidanc fulli consolid maurepa
updat estim note ebitda estim fulli consolid
maurepa consist semg report previous includ
semg share ebitda back non-semg maurepa ebitda dcf
calcul forecast ebitda
dcf
review model updat
oper result lighter expect manag
separ two list entiti infraco enterpriseco slate late
updat valuat sum part result price target
previou follow discuss ceo cfo see favor
prospect zayo share recoveri
zayo post lighter-than-expect result report revenu
compar rbc/consensu weaker-than-expect
result across ci segment ci recur revenu growth vs
target reflect on-going challeng ramp-up
salesforc product lower result carrier vertic channel
manag announc plan separ compani two publicli
trade entiti late updat valuat approach sum
part pt previou
valu usd unless otherwis note
valu usd unless otherwis note
on-going tenant issu persist significantli weigh result
believ mrt continu face signific challeng highlight
earn report headlin result fell well short estim
consensu manag significantli reduc earn guidanc
report ffo company-defin fall well short
estim consensu respect
note shortfal almost entir driven issu oper
texa portfolio
tenant paid million cash rent quarter compar
contractu rate million therefor manag place leas
non-accru statu recogn cash rent wrote million
straight-lin rent
manag sign new leas creativ solut healthcar
take texa portfolio current leas affili
onpoint new oper expect take receiv regulatori
approv expect januari pay annual base rent
million reflect million reduct
valu usd unless otherwis note
market data usd financi data usd dividend paid
see dose respons efficaci fall st expect
see sign dose-respons nsclc
set data remain limit challeng interpret biomark
defin subgroup oral present afternoon tsro
present top-lin efficaci data nsclc expans cohort
amber studi target antibodi
set sign dose respons seen
 combo arm low overal see linger
question surround additive/synergist benefit combo
given challeng cross trial comparison monotherapi trial
present detail pr arm pr
arm combin
orr part trial though note respond cohort
high expressor orr observ
restrict data popul follow question
audienc discuss focus respons rate need
driven arm efficaci bar set chemotherapi post-cpi
set quit high report orr upward upper
orr salvag chemotherapi post-chemo post-cpi set leger et al
jco establish rel high wide efficaci bar
expect report line street estim compar
estim revenu rbce street revenu estim
attribut differ ep estim street
possibl dilut associ account compani incent unit
topic quarter question quarter includ revenu growth
especi organ ebitda ebitda margin share outstand
dilut incent unit pipelin
revenu growth estim revenu increas y/i
pro forma basi organ revenu growth previou
quarter pro forma basi total revenu increas organ growth
adjust ebitda forecast adjust ebitda
margin compar last quarter last
year effect becom public compani acquisit
possibl driver margin degrad estim
 pipelin last quarter ad new partner firm
acquir base earn furthermor sinc end quarter
acquir addit partner firm acquir base earn
brought total number partner firm final septemb
compani announc silicon valley-bas wealth manag firm lore
merg focu partner firm buckingham famili
thought expect dive retail
valu usd unless otherwis note
thought expect dive retail earn
best near-to-mid-term set up dg
alreadi report think two stock along dg
among best posit coverag near-to-mid-term
remain bullish auto part segment believ advanc drive company-
specif margin expans addit experienc improv car parc trend
dollar gener benefit continu store growth prior invest
price labor better employment/wag environ
stock highlight remain bullish risk/reward famili
dollar seem valu close zero believ famili dollar trend
remain soft compani may need ratchet-up labor remodel
invest turn chain shorter-term neg gener long-term
posit seem eye come tariff storm creat
increment earn risk cycl easier comparison
roll new fulli digit strategi major market year-
end stubbornli high use vehicl price increas momentum on-
line competitor continu dent posit thesi recent
downgrad due slight moder ebit growth seemingli high
expect view stretch valuat continu
gain momentum/market share like continu invest busi
outlook profit growth remain subdu
natur grocer vitamin cottag inc nyse
believ pois show strong compar store sale ep beat
promot activ refined/reduc traffic trend held strong
result compar store sale acceler increasingli profit way
ahead street comp ep quarter believ
guid meaning ep growth reiter outperform pt
sharp deceler comp
began aggress promot fall promot activ
refined/reduc traffic trend held strong result compar store
sale acceler increasingli profit way believ pois
show strong compar store sale ep beat composit
compar store sale favor profit price worth
volum earn averag check strong
y/i earn upsid reduc discount dramat
believ anniversari event august great success
amazon/whol food promot vitamin august actual less
whole food use run ahead consensu rbce comp
vs con rbce ep vs con also believ
guid meaning ep growth rbce vs con
reiter outperform pt
valu usd unless otherwis note
valu usd unless otherwis note
report oct-qtr result novemb market close revenue/ep
estim larg in-lin consensu
need know think posit report modest upsid
vs current expect report result toward high-end guid
upsid see larg driven better strength
broader storag spend especi on-premis hybrid environ
public spend sale upsid driver oct-qtr data
point suggest spend fairli robust gross-margin see modest
upsid vs expect given lower memori cost partial off-set invest
cloud volum ela could anoth sourc rev/gm upsid lq
net/net think report upsid quarter guid
larg in-line expect though think execut becom critic
next quarter see two distinct headwind emerg dell/
emc competit difficult compar strong spend year
maintain sp target
dawn roman empir analyst meet preview
outperform-r new-ceo mike roman host first analyst meet
unveil strateg vision guidanc five-year
target eye previou five-year target
ep compound-annual-growth-rate given reput canary-in-a-coal-min signal cycl
inflect simmer concern whether miss portend
new-ceo mike roman unveil five-year guidanc framework
host analyst meet innov center outsid
st paul mn new-ceo mike roman unveil oper
strategi long-term vision refresh target current
framework call organ growth ep compound-annual-growth-rate
believ potenti trim target would
view disappoint note averag organ
growth sinc near low-end guidanc addit three-year
ep compound-annual-growth-rate includ lift us tax reform
bake origin plan exclud tailwind ep grew
compound-annual-growth-rate manag guidanc much due
increas headwind cost inflat fx still clear prior
target need revisit new guidanc project
organ growth reflect bia mr roman toward set
beatable/conserv target expect provid updat busi
transform estim produc mil save
next leg product journey focu commerci
initi suppli chain improv erp roll-out nearli
complet reiter price target
valu usd unless otherwis note
revisit model post dsuvia approv recent financ chang view
dsuvia approv equiti financ support launch roll-
behind us revisit model make sever adjust
includ un-risk adjust dsuvia updat expect around zalviso focu
like shift roll-out dsuvia primari valu driver
came high level fda back approv chang target
dsuvia approv came fda commission attent rational
behind approv link launch set approv come
without debat given adcom vote support news
headlin adcom approv look forward believ dsuvia
go fill uniqu need market singl dose applic acut
pain use medic supervis set swallow pill get
access iv may possibl conveni see potenti broader
displac iv ambulatori set potenti disrupt
add option launch take place follow recent
financ million cash hand million
end pre-financ
valu usd unless otherwis note
outlin catalyst differ posit
receiv mani question surround perform price catalyst
keep messag in-lin introduc road-map next
outlin catalyst differ also take quick attempt
price metric new epyc chip high convict
futur note like continu volatil believ
full year stori investor sentiment shift like start
download model updat rams confirm safeti seen
continu like respect fda/ema regulatori
submiss plan potenti commerci launch
new ceo jayson dalla see peanut allergi desensit efficaci
unparallel buyer grow becom standard care
indic potenti tailwind biolog combin
combo initi
valu usd unless otherwis note
valu usd unless otherwis note
updat see rams top-lin readout confirm safeti profil
seen palisad report financi result includ top-lin
data rams trial appear larg mirror safeti
result report previous palisad updat also ad addit
catalyst plan decemb analyst event nyc
public palisad trial data peer-review public
releas note rams safeti experi consist safeti
profil observ previous report pivot phase palisad trial see
full result takeaway hope rams could improv upon
surprisingli benign safeti profil seen palisad given lack allergen
prime omiss allergen food-challeng studi entri
note result suggest palisad trial data highli align
like real world experi continu like anticip
regulatori approv commerci guid bla fda
submiss artemi trial support file europ
expect file
stay cours maintain target outperform
believ volum issu long-term concern importantli
seen soft realiz price result increment lithium
project believ custom demand contract secur suppli
posit realiz price demonstr heavi demand high qualiti
batteri grade lithium reaffirm posit thesi
report ep our/street estim
ebitda came line street
major downsid vs model lithium
segment bromin catalyst came slightli ahead expect
fy guidanc maintain ebitda
ep midpoint impli consensu manag
anticip low y/i ebitda growth lithium lower slightli given
lower volum said manag continu anticip mid-to-
high singl digit price year believ demonstr higher demand/
price high qualiti batteri grade lithium rel overal lithium
moder spot hydroxid price priorit hydroxid
project kemerton given increas demand custom secur longer-
adjust fy number reflect updat
guidanc near midpoint moder lithium volum
expect maintain exist estim adjust
volume/pric expect lithium busi
maintain outperform near-term bear persist would highlight
strong demand new energi vehicl china custom demand long-term
contract contract volum price level equal
average sell price balanc sheet flexibl reason continu
stock
steadi goe reiter outperform
in-lin quarter thesi chang continu believ
share algonquin outperform peer due attract histor futur
growth profil pursu opportun regul util contract power
divis contract intern develop indirectli atlantica
invest opportun ramp manag note
agreement reach atlantica yield particip
peru transmiss develop transfer project atlantica
yield follow complet fid expect beyond manag
indic aag develop jv pursu water desalin
california north africa wind project uruguay
manag see minim risk power claim octob
junior renew develop power commenc action ontario
superior court justic algonquin claim damag million
punit damag million action aris power
sale certain propos wind farm algonquin name chaplin amherst
wind power entitl royalti payment subject offset
project develop achiev certain agre target accord
manag fulli intend pay royalti subject offset
estim less million per year amherst wind project
upcom investor day provid addit detail support strong
growth profil algonquin host annual investor day toronto
new york decemb respect expect manag
provid updat outlook support growth
profil without reli manag indic would
provid addit colour opportun pursu aag
thought bull vs bear these
need know stock come pressur post ep call
stock sinc earn vs essenti flat share
key bull bear argument think bull case dilut
somewhat near term head next quarter could see
news report suppli chain data point indic mute demand new
gener iphon howev think continu lever beyond
unit growth includ servic growth buyback support
continu ep growth longer term net/net maintain op price target
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
sound silenc athena report soft result
athn report result compani miss consensu book
revenu beat ep compani provid updat sale
process expect compani address topic monday earn
call latest
athn report ep beat driven low sale market spend miss
revenu book line importantli give updat
on-going sale process expect get updat monday
takeaway ceo meet
host investor meet ceo fred lissald ir pat nolan
macro concern weigh stock see compel mid-term growth
opportun reason price prefer way play powertrain
evolut within supplier coverag
china remain forefront wltp subsid manag frank
indic china difficult forecast right part
reason guid wide organ growth rang
factor impact guidanc wltp overal manag believ
noth structur chang europ wltp issu resolv
confid outgrowth offici commentari februari
manag remain confid grow double-digit china given
strong demand dct hybrid bev content europ abl
outgrow region lsd na even market
believ grow msd-hsd
debat motor continu believ insourced/
outsourc win share outsourc compon vs
share said time econom could prevail
supplier may abl gain greater scale oem oem
area invest
result take busi
valu cad unless otherwis note
valu usd unless otherwis note
enerplu corpor third-quart result reinforc confid game
plan compani remain amongst favorit intermedi produc given
consist oper financi perform conserv balanc sheet
capabl manag team prospect continu share buyback
dj basin develop ad sizzl stori maintain outperform
recommend enerplu one-year target price per share
compani strong third-quart result punctuat higher
product along favor guidanc updat pleasant surpris
accompani result form enerplu signal also begun act
ncib million repurchas thu far compani
expect repurchas continu base upon current market condit
dj basin enerplu make solid progress line sight
competit develop econom emerg compani drill
gross net well play first well mapl produc
approxim bbl oil first month product
result addit four well complet quarter
encourag enerplu plan continu delin drill progress
midstream option potenti proposit issu
essent deliv strong result remain solid growth loss ratio
environ mortgag insur essent also continu produc signific
expens ratio improv new pmier capit standard
non-ev remain outperform share view compani
gener strong top-lin growth gener highli profit
combin ratio roe
estim rais ep estim captur
upsid well slightli favor combin ratio assumpt
also increas ep estim
mostli due better invest incom expens
ratio assumpt rel previou estim
top expect essent report adjust oper ep
vs ahead estim consensu estim
upsid estim mostli due better-than-expect combin ratio
larg expens ratio well higher-than-anticip earn premium
net earn premium grew million forecast
reflect higher-than-expect insur forc growth premium yield
posit strong new insur written earn premium growth
expens ratio improv point y/i basi default rate
fell remain well
neg capit manag action unlik near term
tax rate came point higher estim recent improv
persist ratio might sustain
preview cheat sheet
eventbrit report first public compani ep result monday novemb
detail key item watch note
eb report result novemb forecast revenu
slightli street adjust ebitda
street eventbrit start trade publicli
septemb issu share common stock includ
overallot share eb offer share per share
high end updat price rang per share initi
price rang per share
valu usd unless otherwis note
valu usd unless otherwis note
earli sign potenti inflect point
post anoth quarter increment improv show first quarter
yoy store adjust ebitdar growth sinc reinforc indic
snf industri could reach inflect point
deliv anoth quarter improv beat street expect
improv continu encourag macro trend seen
first half year
portfolio ration track macro headwind eas
manag post first quarter same-stor adjust ebitdar growth
sinc compani report stabl alo yoy among skill
censu encourag chang persist downward trend
pressur occup addit wage inflat continu
outpac rate growth gap narrow solid rate increas among
govern payor averag medicaid moder wage growth
extens review potenti impact plan implement
pdpm snf manag cautious optimist potenti
upsid notabl reduc patient assess requir
flexibl around therapi modal could potenti reduc cost
continu deliv strong qualiti score exceed industri averag
particularli rn staf bode prospect
futur value-bas initi compani roughli portfolio
ration effort result signific reduct cash leas
payment proce debt reduct
also complet opportunist acquisit nine facil nm
az headwind remain encourag sign inflect
updat model result featur in-lin revenu slight
ebitda beat unchang guidanc meet incom cfo john
doherti vice-president investor relat highlight solid demand book trend
platform vertic continu primari growth driver provid
greater visibl futur deploy
market data usd financi data eur dividend paid
valu usd unless otherwis note
inxn report solid quarter in-lin revenu y/i
report fx-adjust adjust ebitda slightli better
consensu higher expect margin manag continu see
solid demand reflect book sale pipelin platform
vertic continu primari growth driver provid greater visibl
futur deploy manag re-affirmed previous provid
guidanc estim revenu previou
ebitda previou
maintain price target
manag continu focu effort improv capit effici seismic
data usag oil firm sale agreement optim develop
compani seek partner goal capit
econom deploy
look partner roughli acr current
hbp well need fulfil hbp oblig compani seek
partner help develop portion acreag would allow capit
realloc full-field develop whiskey river cochis fulli
process seismic expect help firm decis
around drill think compani select let acreag go
compet
strong quarterli execut refin complet design continu
provid increment gain well product compani also make
stride improv footag drill complet per day use zipper
frac pad develop show improv later footag
complet per day compar quarterli averag demonstr
substanti run room futur effici
assur price diversif secur price provid new
firm transport agreement think compani pay receiv meh
base price contract cover mb/d gross product begin
cactu ii estim crude
product compani also extend agreement oryx
provid flow assur region market midland
valu usd unless otherwis note
valu usd unless otherwis note
consumer/rx separ analysi re-set ep still lack upsid level
new ceo place continu commit separ rx earli re-
set behind us revisit analysi look stand-alone remain-co ep
bottom line despit share declin new analysi fail support upsid risk
anoth re-set remain continu watch close yet readi
move cautiou stanc remain sector perform target
new analysi drive platform valu line fundament
target modestli current stock price reflect spin-co
like separ new analysi detail exhibit remain-co
ep benefit shift million debt spin-co
discount global brand consum peer get us price-to-earnings impli valu
given earn declin limit much leverag spin-
co like take gross leverag remain-co per analysi put
sector averag ebitda multipl like debat rx spin-co
get per share collect leav platform valu
continu watch close yet readi move
cautiou stanc remain sector perform target make chang
forecast outlook
control control
despit difficult use equip suppli dynam manag leverag
multi-channel platform drive higher commiss rate new product/servic
offer still earli day ritchi transform provid
attract long-term upsid option see near-term earn potenti
near fair valu look improv suppli dynam
monet new product/servic offer becom posit
continu headwind gross transact valu gtv came vs
estim y/i despit ironplanet fold
manag though continu good job manag oper
auction marketplac commiss improv y/i
drive agenc proce higher manag note call see
materi chang exist gtv trend although cautious optimist
suppli dynam improv key manag focus
grow agenc proce find way agenc proce
y/i
transitori structur part sector perform thesi base fact
see current constrain equip suppli issu prolong
partial structur oem distributor look extract life-cycl
econom equip sell
maintain sector perform adjust gtv growth
assumpt forecast horizon howev also increas
agenc proceed rate conjunct larg offset net/net ep
remain unchang appli price-to-earnings multipl get
price target provid all-in impli return target basi
sector perform rate
valu usd unless otherwis note
misunderstand strong quarter result
sun result came ahead expect even exclud
one-tim benefit high-margin acquisit optim effort favor
fundament drove higher gross margin/gallon sun also remain focus
execut bolt-on acquisit bring commerci synergi tweak
estim maintain outperform rate price target
idr elimin least wake close energi
transfer simplif transact sun manag note neither sun
et spent effort discuss potenti idr restructur sun
confid partnership abil grow creat valu lp
gp see urgenc address idr particular case
would surpris us issu gain increment interest time
higher margin drive strong result sun report adjust ebitda
vs our/consensu dcf vs our/
consensu importantli sun report strong margin even
exclud benefit drove beat manag expect trend
continu driven sun optim strategi higher-margin acquisit
bolt-on strategi sun complet acquisit brenco fuel
distribut busi octob note robust acquisit pipelin robust
sun remain confid abil fund acquisit prefer equiti
offer could help cover equiti portion growth program
capit alloc prioriti distribut coverag strengthen
recent quarter sun expect continu build coverag excess cash
gener manag also note increas distribut current
environ may take back seat consid altern use cash
fund growth pay debt
updat estim forecast ebitda
dcf
post rais result modestli deceler subscript
revenu record-high ebitda margin rais revenu guidanc reiter
outperform pt present rbc timt confer nyc
nov
rais revenu outlook total revenu beat
rbc/street high-end guidanc
beat come revenu subscript revenu miss
street ebitda rbc/street
term outlook manag look
revenu street fundament trend
gener posit deceler revenu growth
pt tougher comp ebitda margin q/q y/i record high level
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
updat aasld day
fxr nash look modest earli hbv econom burden nash
attend aasld access poster avail earli
view well present today -- notabl nash
data fxr agonist agonist hbv health econom data
burden nash
discontinu equiti research coverag educ realti trust inc due
acquisit greystar estat partner gramerci properti trust
due acquisit blackston estat partner respect
valuat tabl power price frac spread data rel price perform
ex-dividend date
highlight weekli ag note
project us soybean sale china china revis corn output believ
china stretch soybean suppli wheat price ksk grain termin expans
russia increas soybean prod export china
gener pharma data point tell us
told us thesi cyclic upturn come
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
leav best describ in-lin averag low expect
cautious optimist tone year-to-d stock perform still
volatil teva book-end wide dispers
last three month sector revis trend mute
gross margin flat ebitda increment lower
importantli enter look color five specif theme per
note link directli feed view still earli gener
sector see cyclic upsw move overal debat
around sector outlook continu still earli come away
updat loan week
weekli industri loan non-season adjust loan
week-over-week w/w basi end octob year-
over-year y/i basi follow trend
commerci industri w/w y/i
consum w/w y/i
commerci estat w/w y/i
residenti estat w/w y/i
equiti w/w y/i
w/w y/i
hd/low tweak pt stock seem re-bas macro
us hous stock pressur due sign soft
broader hous market hd immun
stock lost multipl turn sinc recent high given rise mortgag
rate complet reason expect home sale slow howev
import metric improv segment busi
exist home inventori level home price appreci pfri growth
remain posit pfri increas roughli similar
last sever quarter given shift investor sentiment potenti
slower futur growth inventori level build home price start
declin reduc multipl target compani hd
reduc price-to-earnings target ntm ep estim in-lin
histor rel multipl pt goe
expect comp investor like rang bp
margin pressur transportation/fuel cost headwind ep roughli
in-lin consensu price-to-earnings target goe
modest premium histor rel multipl due compani recent
manag chang pt muddi
compani move piec model comp ep
includ bp increment gm pressur due inventori clearanc activ
imdz/dvax updat addit support go-forward
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
attend washington dc imdz present
new data support dose chosen upcom clinic trial
compar abstract releas tuesday today poster includ data
addit patient best overal orr improv
group
signific associ amount immun cell infiltr induc
 clinic respons tumor shrinkag lymphoma melanoma
week novemb
rundown number earn season coverag
list essenti complet took closer look quarterli result
number favor market condit better economi rise interest
rate help sector condit pretti good insur
underwrit margin ep improv significantli easi comparison
ratio beats/miss better life insur
view result mainli posit light mostli good news
annuiti group benefit life bit construct life
insur insur valuat attract roe comfort
doubl digit top-lin remain healthi
notabl notabl earn werent game town last
week comment notabl item may miss earn
season includ thought renre-tokio millennium deal well
 potenti includ possibl sale annuiti
busi also make round cat loss elect worker comp
rate well someth extraordinari
cyber insur solidifi busi line recap recent joint report
partnerr advisen found grow level price
product consist product matur lack understand risk
coverag seem among main factor inhibit growth though news
regard breach continu drive sale
 of daili
contract adnoc onshor letter abu dhabi opec cours correct
come oil strategi spotlight chines demand jersey oil ga jog
largest increas largest declin
averag short interest percentag float coverag
two-week period end octob period end
stock highest short interest
respect post largest increas short
interest percentag float octob period
mueller water lowest short interest level
lincoln electr equip servic tie second lowest
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
post largest declin short interest percentag
float respect
never dull moment start weekli follow earn data heavi
week review biotech coverag univers end week
remain ytd see exhibit note tsro end week
data see note end week
follow push data per file rarx end week
despit posit commentari ahead gmg data bu tour
see note end week follow sell-off see
note
rbc/consensu expect head
result call exclud compani decreas
distribut y/i basi tcp bkep capl bpl averag distribut
growth slightli ahead estim consensu
theme final week earn fundament remain gener
strong across midstream except crude oil storag preliminari
guidanc gener better line consensu expect
proposit pass howev oper colorado work
toward long-term solut question simplif transact
idr restructur remain topic heel western ga announc
simplif
proposit outcom saw signific ralli week stock
exposur colorado prop fail pass note howev
prevail sentiment remain signific amount work ahead
ensur stakehold reach mutual conveni agreement short-
term may see produc continu acceler permit anticip
similar proposit make ballot next elector cycl
midstream confer host annual midstream energi
confer novemb dalla tx compani
hold break-out session meet pleas contact sale rep
detail
highlight weekli mine note includ chile copper prod ytd
sep dealer fin result eia st energi outlook sumatra
shougang port hedland iron ore shipment bhp rail activ queensland
news nashvil
weekli perspect healthcar industri compani news valuat
sector price perform week end novemb healthcar servic
stock outperform broader market health servic select
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
spsihp gain versu gain
skill nurs strongest-perform sub-sector last week
post gain acut hospit gain versu gain
prior week manag gain versu flat perform prior
week weakest-perform sub-sector last week institut pharmaci
pleas find recent video edit news nashvil
recap earn well post-elect commentari
cvs/aet
week watch resolut athena sale process
progress cvs/aet deal close also listen
present confer tuesday wednesday
hpc set buy stake kishor biyani-l
futur retail ltd india glaxosmithklin consum healthcar announc
new innov theraflu cold flu symptom relief launch
theraflu powerpod sever procter gambl enter joint
develop licens agreement envanc technolog maker
insecticid formul avoid endang peopl
beverag coca-cola compani talk invest dirti lemon beverag
llc direct-to-consum beverag compani accord unconfirm
report busi insid novemb frito-lay announc voluntari
recal select oz bag smartfood delight sea flavor popcorn
inadvert fill chees flavor tortilla chip
contain undeclar milk ingredi drive innov
fast grow spirit categori launch tequila mi campo
tobacco juul struck deal sainsburi first suppli agreement
major uk retail accord agreement juul suppli
sainsburi store start novemb imperi brand signal
invest vape report better expect full-year revenu
profit quarter compani prepar launch heat tobacco
product japan first quarter
continu digest learn last week
wood product lumber spf continu upws
syp continu correct osb market
stabil emerg potenti bottom found flat week north
central eastern canada flat
respect us south east south west
pulp paper packag london pulp week highlight trade journal
near-term correct spur china weak risi report london pulp
week particip note on-going concern long-term suppli avail
newli develop price volatil china whether sharp declin china
bsk would spread markets/grad nbsk report
tonn sop price fall first time year us average m/m
average us occ price tick accord risi contact
report tissu mill began refus sop ton mill continu run high
valu usd unless otherwis note
valu cad unless otherwis note
valu cad unless otherwis note
remain extrem comfort inventori also seem shift
away sop input nd paper fairmont va recycl pulp mill
impact well
top investor question week payment processor servic
quick summari question topic includ payment processor
servic firm rbc annual timt confer might miss
cloud technolog ach transact growth best worst perform
stock week respect thursday close thursday
group trade lower w/w p/tsx
transport w/w bombardi notabl laggard w/
 follow mostli in-lin releas thursday howev guidanc
reduct spook market posit side wte
week follow strong releas cp
respect remind investor annual shipper survey
automot diversifi industri w/w strength sector
led share w/w compani announc
extens enhancedview contract mg share w/
 compani report solid perform lnr mre
w/w respect report disappoint
result although encourag commentari confer
call regard impress growth trend core label segment
industri product w/w ftt tih w/
 respect report result wsp report net revenu organ
growth adjust ebitda margin ltm
manag unveil strateg plan earli
view potenti catalyst stn report solid result consult
servic segment highlight net organ growth adj ebitda
margin
survey tap view class railroad top custom
pleas present find edit annual shipper survey
find center shipper expect regard rail rate
volum growth servic level market share shift cn vs cp well truck
vs rail new year immin persist capac issu highlight
element
price growth acceler anoth big year rail
price averag price growth rate anticip shipper per
survey acceler last year
shipper expect record year volum growth volum growth
expect push highest level seen sinc conduct
survey averag last year
capac remain issu volum increas shipper notic
emerg case continu capac constraint class
valu gbp unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
rail shipper flag cn risk avail capac
servic impact capac constraint cp widen lead
canada proport posit servic rate rail slip
last year push overal satisfact rail servic lowest level
fortum updat strategi ahead unlik move unip
environment law group submit object drax propos plant
engi invest biomethan next five year
state-back isif fuel renew energi fund
 spak micro-mobl multi-mod transport
perhap greatest emerg theme transport
micro-mobl rise e-scoot e-bik tri solv last mile
mobil micro-mobl key prong make concept multi-mod
car ownership ride-shar av public transport micro-mobl yield
effici trip
transport network compani top concept
mani alreadi move integr bike scooter system
automak taken note past week saw flurri action
question oem remain old-world industri compani adapt
fast enough better
sever notabl big move period closer look
look sector short interest exhibit period end
saw overal si move higher median flat market-weight basi
short interest among coverag move slightli lower exhibit
big move took closer look also highlight
follow move period captur earn
link result take back seat frustrat around messag includ
felt like walk-back around anticip divestitur ii
stock continu sell-off sinc juli high vs flat given on-going
concern around xhanc earli launch progress report
road iii period came prior cch
data result link concern around former led meaning
pull-back short interest continu increas
period million share follow last period move ii short
interest decreas million share remain cautiou could
anoth feb/mar earn re-set iii short interest decreas
million share coincid materi low expect head
specialti pharma focus week
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
leav bulk specialti pharma earn behind us shift busi
week road aqst trip
specialti pharma coverag collect
aqst expect focu shift earn year-end posit
lead sell-sid outlook season three biggest debat come
past week saw vyxeo near-term frustrat
valu seemingli unlock ii oversold share cch peak
potenti debat iii risk new re-set still re-set
takeaway bancanalyst associ boston
year theme focus relev age big data
highlight bancanalyst associ boston year theme
relev time big data
week host annual timt confer new york public
rp rht shop data
slack snowflak sonatyp sprinklr confer preview
pic week highlight coup formal move payment
formal coupa pay user event london last week
optimist fourth pillar addit procur expens invoic
manag scale spend volum time
also recap last week earn includ mime
news nashvil
video content
 beyond elect result
valu usd unless otherwis note
valu usd unless otherwis note
past week initi convers around three non-deal road
show sponsor ay investor interest stem
seek low risk qualiti name uncertain stock market mani investor
question focus sustain model investor sentiment
remain posit predispos toward stock hesit come
valuat garner strong interest two-day meet london
remain one util stock shade investor seek turn
ay investor seem pleas recent earn releas particularli
increas visibl growth opportun common question
focus growth pipelin upcom analyst day
time friday came along thought wrap earn prepar
eei california wildfir rear ugli head talk number
investor tri figur whether share weak california
util least repres prudent entri point
tempt buy given close stock price friday
seem headlin risk might horizon tri address
wildfir offer assur keep util financi credit-
worthi though defin term bill seem offer less protect
subsequ wildfir concern may volatil
day ahead
attend annual aagl confer focus
confer host breakfast wednesday
novemb grand hotel host surgeon event
tuesday novemb estimate
non-deal roadshow cfo novemb recent
report result in-lin pre-announc earli
octob earn call issu guidanc senhanc
system sale revenu driver share
next month includ fda approv new instrument technolog
veith symposium highlight elgx leopard studi believ
leopard data come opportun time fda issu recal afx-
strata octob worth note afx-strata complet market
believ leopard data re-engag physician continu use afx/
durapli
buyer post analyst meet left meet feel
confid manag abil deliv organ top-lin growth y/i
rang oper margin expans despit dilut
recent deal view one strongest grower large-cap
med-tech remain buyer stock
tail end larg cap home stretch small cap stat captur
activ thursday nov result
russel result report season final day
compani set report week ahead smid cap report season
also wind compani russel expect
report last week biggest week smid cap report season well
compani result came
beat consensu pace clearli moder far
 compani report beaten consensu ep
expect line last week updat beaten consensu
sale slightli last week track still
come notch level pace ep beat hit time
high deceler pace sale beat continu much sharper
weve seen ep current trend hold quarter
row pace sale beat fallen page
oil strategi spotlight chines demand
weak macroeconom indic caus havoc global oil market
deep dive focus world largest demand growth countri look
dispel myth misconcept highlight bright spot
chines oil demand soften econom backdrop real question
elast relationship chines oil consumpt
histor rule thumb lead surprisingli mislead conclus
composit chines growth shift recent year distil
gasolin intens behind passeng mile driven china higher
mean relationship petrol demand growth
less elast ever
jet fuel underappreci compon chines oil demand
often miss mani sinc aviat fuel simpli radar mani
market particip segment market contribut chines
demand growth either distil gasolin
capit market technolog internet media
novemb new york citi
welcom capit market technolog internet media
telecommun confer new york citi year confer
compani repres broad spectrum timt univers present
institut investor report intend comprehens guid
refer tool confer part preview global
research highlight key sector-level theme provid company-
specif question manag chief us equiti strategist lori calvasina
contribut perspect technolog space provid macro context
view technology-ded analyst full confer agenda
also includ conveni alway encourag
follow team addit dialogu sector invest
overarch goal report challeng manag investor
think creat framework help anticip compani
front foot strateg leadership decis today may well determin
compani fate histor chang exampl illustr throughout
report demonstr encourag reader take later approach
review report read section reflect upon develop
one industri may influenc anoth hope themat roadmap
includ global list forward-think compani highlight
imagin portfolio challeng execut asset manag think
expans creativ invest eye toward next decad
letter abu dhabi opec cours correct come
though ministeri monitor committe meet yield
firm product decis clear indic signific
polici revers of decemb opec meet
firm commit collect product cut decemb leadership
joint ministeri monitor committe indic polici urg
percent complianc conclud current complianc
jmmc declar vienna allianc produc go
ad barrel market matter polici instead would
activ consid curtail suppli advanc decemb meet uae
oil minist opec confer presid suhail mazroui particularli
forc point cite rise suppli necessit end
output increas experi indic varieti option
consid opec non-opec nation come week
capit market busi name use certain branch subsidiari royal bank canada includ dominion secur inc
capit market llc europ limit royal bank canada hong kong branch royal bank canada sydney branch inform contain
report compil capit market sourc believ reliabl represent warranti express impli made royal
canada capit market affili person accuraci complet correct opinion estim contain
report constitut capit market judgement date report subject chang without notic provid good faith without
legal respons noth report constitut legal account tax advic individu tailor invest advic materi prepar gener
circul client prepar without regard individu financi circumst object person receiv invest
servic contain report may suitabl recommend consult independ invest advisor doubt
suitabl invest servic report offer sell solicit offer buy secur past perform guid
futur perform futur return guarante loss origin capit may occur capit market research analyst compens base
part overal profit capit market includ profit attribut invest bank revenu everi provinc canada state
 countri throughout world law regul type secur invest product may offer
resid well process result secur discuss report may elig sale jurisdict
capit market may restrict publish research report time time due regulatori restrict and/ intern complianc polici
case latest publish research report avail client may reflect recent materi chang applic industri and/or applic subject
compani capit market research report current date set forth research report report circumst
constru solicit act secur broker dealer jurisdict person compani legal permit carri
busi secur broker dealer jurisdict full extent permit law neither capit market affili
person accept liabil whatsoev direct consequenti loss aris use report inform contain herein matter
contain document may reproduc copi mean without prior consent capit market
addit inform avail request
public approv capit market llc member finra nyse sipc regist broker-deal accept
respons report dissemin unit state recipi report regist broker-deal bank act
broker dealer capac wish inform regard effect transact secur discuss report
contact place order capit market llc
public approv dominion secur inc member iiroc canadian recipi report design institut
ontario accredit investor british columbia alberta sophist purchas quebec similar permit purchas provinc
wish inform regard effect transact secur discuss report contact place order
dominion secur inc without way limit forego accept respons report dissemin canada
public approv europ limit el author prudenti regul author regul
conduct author fca prudenti regul author connect distribut unit kingdom materi gener
distribut unit kingdom retail client defin rule fca rbcel accept respons report dissemin
unit kingdom
materi distribut germani europ limit frankfurt branch regul bundesanstalt fr finanzdienstleistungsaufsicht bafin
receiv advic australia
materi distribut australia royal bank canada sydney branch abn afsl materi prepar
gener circul take account object financi situat need recipi accordingli recipi act
materi consid appropri materi regard object financi situat need materi relat acquisit
possibl acquisit particular financi product recipi australia obtain relev disclosur document prepar respect product
